Literature DB >> 9085461

Worry associated with screening for colorectal carcinomas.

E Lindholm1, B Berglund, J Kewenter, E Haglind.   

Abstract

BACKGROUND: We wanted to assess the worry created by a screening program for colorectal cancer with fecal occult blood testing.
METHODS: Six thousand three hundred and sixty-six individuals (47% men; 53% women) were asked to what extent they were worried when they received an invitation letter including a Hemoccult II test (HII). The questionnaire was supplemented by a structured telephone interview of a selected number of individuals with different outcome of the HII.
RESULTS: Three thousand four hundred and eighty-six subjects performed the HII test, and 3548 (56%) answered the questionnaire. Eighty-four per cent (n = 2932) of the participants and 21% (n = 616) of the non-participants completed the questionnaire. Half of the participants (54%) were not worried at all, but 16%, more women than men, felt severe worry, which lasted less than 1 week in 59%. In 4.7% of the participants daily life was negatively influenced by the invitation letter. In the telephone interview 19% reported severe worry before they received the result of the first test, and in 5.8% daily life was negatively affected. The worry rate increased to 60% in the groups with an initial positive HII test, and in 15% daily life was negatively influenced. After the examination the worry decreased in most but was still pronounced in 10%. One year after the work-up 96% declared that they appreciated the study. Subjects with only elementary school education expressed more worry than those with a higher level of education (P < 0.05).
CONCLUSIONS: Severe worry in connection with the invitation was reported by a minority of the invited participants, more women than men. The worry increased among those who had a positive test but decreased after the examination. One year after the work-up most appreciated the study.

Entities:  

Mesh:

Year:  1997        PMID: 9085461     DOI: 10.3109/00365529709000201

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  No association between colorectal cancer worry and screening uptake in Appalachian Ohio.

Authors:  Adana A Llanos; Michael L Pennell; Gregory S Young; Cathy M Tatum; Mira L Katz; Electra D Paskett
Journal:  J Public Health (Oxf)       Date:  2014-05-20       Impact factor: 2.341

Review 2.  How does the social environment during life course embody in and influence the development of cancer?

Authors:  Ming Chen; Huiyun Zhu; Yiqi Du; Geliang Yang
Journal:  Int J Public Health       Date:  2018-06-11       Impact factor: 3.380

3.  Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-09-01

4.  FIT false-positives in colorectal cancer screening experience psychological distress up to 6 weeks after colonoscopy.

Authors:  M J Denters; M Deutekom; M L Essink-Bot; P M Bossuyt; P Fockens; E Dekker
Journal:  Support Care Cancer       Date:  2013-06-01       Impact factor: 3.603

5.  A randomized questionnaire-based study on the impact of providing numerical information on colorectal cancer screening.

Authors:  Imran M Patanwala; Victoria Brocklebank; Janet Inglis; Peter N Trewby
Journal:  JRSM Short Rep       Date:  2011-06-13

6.  Persuasion, Adaptation, and Double Identity: Qualitative Study on the Psychological Impact of a Screen-Detected Colorectal Cancer Diagnosis.

Authors:  Lesley M McGregor; Sara Tookey; Rosalind Raine; Christian von Wagner; Georgia Black
Journal:  Gastroenterol Res Pract       Date:  2018-06-07       Impact factor: 2.260

7.  Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis.

Authors:  Henriette C Jodal; Lise M Helsingen; Joseph C Anderson; Lyubov Lytvyn; Per Olav Vandvik; Louise Emilsson
Journal:  BMJ Open       Date:  2019-10-02       Impact factor: 2.692

8.  Quality of life in participants of a CRC screening program.

Authors:  A Kapidzic; I J Korfage; L van Dam; A H C van Roon; J C I Y Reijerink; A G Zauber; M van Ballegooijen; E J Kuipers; M E van Leerdam
Journal:  Br J Cancer       Date:  2012-09-06       Impact factor: 7.640

Review 9.  Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals.

Authors:  Øyvind Holme; Michael Bretthauer; Atle Fretheim; Jan Odgaard-Jensen; Geir Hoff
Journal:  Cochrane Database Syst Rev       Date:  2013-10-01

10.  Patient-reported impacts of a conservative management programme for the clinically inapparent adrenal mass.

Authors:  Andreas Muth; Charles Taft; Lilian Hammarstedt; Lena Björneld; Mikael Hellström; Bo Wängberg
Journal:  Endocrine       Date:  2012-12-20       Impact factor: 3.633

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.